Fortress Biotech, Inc.
NASDAQ:FBIOBiotechnology
-$0.06 today
- Market cap
- $59.03M
- Beta
- 1.23
- P/E (TTM)
- 0.7
- EPS (TTM)
- $4.05
Volume 0.19M
Average 0.43M
Dividends
Fortress Biotech, Inc. dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.4%
Frequency
—
Shareholder Yield
1.57%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 0.4%, so compare payout growth against earnings coverage.
Competitor dividends
How does Fortress Biotech, Inc. compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Relmada Therapeutics, Inc. NASDAQ:RLMD | $449.08M | 0.00% | $0.00 | 0.00% | 0.00% |
Immunic, Inc. NASDAQ:IMUX | $102.61M | 0.00% | $0.00 | 0.00% | 0.12% |
Vaxart, Inc. NASDAQ:VXRT | $90.17M | 0.00% | $0.00 | 0.00% | 0.00% |
Nutriband Inc. NASDAQ:NTRB | $74.15M | 0.00% | $0.00 | 0.00% | 0.00% |
PMV Pharmaceuticals, Inc. NASDAQ:PMVP | $67.73M | 0.00% | $0.00 | 0.00% | 0.00% |
Adagene Inc. NASDAQ:ADAG | $64.38M | 0.00% | $0.00 | 0.00% | 0.00% |
XBiotech Inc. NASDAQ:XBIT | $59.76M | 0.00% | $0.00 | 0.00% | 0.00% |
Gain Therapeutics, Inc. NASDAQ:GANX | $44.36M | 0.00% | $0.00 | 0.00% | 0.00% |
TScan Therapeutics, Inc. NASDAQ:TCRX | $10.20M | 0.00% | $0.00 | 0.00% | 0.38% |
Questions
Dividend questions
Common questions about FBIO's dividend, answered from reported figures.
Does FBIO stock pay dividends?
Fortress Biotech, Inc. (FBIO) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is FBIO's dividend covered?
The payout ratio is 0.4%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.